Respiri Ltd - Company Profile
Powered by 
All the data and insights you need on Respiri Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Respiri Ltd Strategy Report
- Understand Respiri Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that conducts research, development, and commercialization of medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma. The company’s proprietary applications, software and devices will help people monitor the symptoms of their conditions and increase their awareness of the risk of attack. It is an Australian e-Health SaaS provider that supports respiratory health management with a primary focus on the US healthcare industry. It offers wheezo, an asthma management tool that helps patients in the management of their health condition. Respiri is headquartered in Melbourne, Victoria, Australia.
Headquarters
Australia
Address
Suite 1, Level 9, 432 St Kilda Road, Melbourne, Victoria, 3004
Website
respiri.co/us
Telephone
61 3 96539160
No of Employees
2
Industry
Medical Equipment
Ticker Symbol & Exchange
RSH (ASX)
Revenue (2023)
$459,200
-15%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
12.8%
(2023 vs 2022)
Market Cap*
$23.5M
Net Profit Margin (2023)
XYZ
-2.6%
(2023 vs 2022)
* As of and is in US$
Respiri Ltd premium industry data and analytics
Products and Services
| Brands |
|---|
| - |
| SonoSentry |
| Wheezo |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In May, the company entered into an agreement to acquire Access Managed Services for US$3 million. |
| 2022 | Contracts/Agreements | In December, the company secured an agreement from Hand Family Healthcare, a primary care practice. |
| 2022 | Contracts/Agreements | In November, the company entered into an agreement with Minnesota Lung Center (MLC) for a pilot program. |
Competitor Comparison
| Key Parameters | Respiri Ltd | Teleflex Inc | Compumedics Ltd | Allied Healthcare Products Inc | Vision Eye Institute Ltd |
|---|---|---|---|---|---|
| Headquarters | Australia | United States of America | Australia | United States of America | Australia |
| City | Melbourne | Wayne | Melbourne | St. Louis | Melbourne |
| State/Province | Victoria | Pennsylvania | Victoria | Missouri | Victoria |
| No. of Employees | 2 | 14,500 | 135 | 146 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Nicholas Smedley | Chairman | Executive Board | 2019 | - |
| Marjan Mikel | Director; Chief Executive Officer | Executive Board | 2019 | - |
| George Vlachodimitropoulos | Chief Technology Officer | Senior Management | 2021 | - |
| Theo Antonopoulos | Chief Commercial Officer | Senior Management | 2021 | - |
| Peter Hildebrandt | Chief Operations Officer | Senior Management | 2020 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer